AI Assistant
Blog
Pricing
Log In
Sign Up
P426. Post-induction adalimumab drug levels predict clinical and laboratory remission at week 24 in patients with Crohn’s disease
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
